Osteochondral repair in the rabbit model utilizing bilayered, degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds

被引:147
作者
Holland, TA
Bodde, EWH
Baggett, LS
Tabata, Y
Mikos, AG
Jansen, JA
机构
[1] Univ Nijmegen, Med Ctr, Dept Periodontol & Biomat, NL-6500 HB Nijmegen, Netherlands
[2] Rice Univ, Dept Bioengn, Houston, TX 77251 USA
[3] Rice Univ, Dept Stat, Houston, TX 77251 USA
[4] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Field Tissue Engn,Sakyo Ku, Kyoto 6068507, Japan
关键词
articular cartilage engineering; degradable hydrogel; gelatin microparticles; in vivo osteochondral defect;
D O I
10.1002/jbm.a.30379
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In this study, hydrogel scaffolds, based on the polymer oligo(poly(ethylene glycol) fumarate) (OPF), were implanted into osteochondral defects in the rabbit model. Scaffolds consisted of two layers-a bottom, bone forming layer and a top, cartilage forming layer. Three scaffold formulations were implanted to assess how material composition and transforming growth factor-beta 1 (TGF-beta 1) loading affected osteochondral repair. Critical histological evaluation and scoring of the quantity and quality of tissue in the chondral and subchondral regions of defects was performed at 4 and 14 weeks. At both time points, no evidence of prolonged inflammation was observed, and healthy tissue was seen to infiltrate the defect area. The quality of this tissue improved over time with hyaline cartilage filling the chondral region and a mixture of trabecular and compact bone filling the subchondral region at 14 weeks. A promising degree of Safranin 0 staining and chondrocyte organization was observed in the newly formed surface tissue, while the underlying subchondral bone was completely integrated with the surrounding bone at 14 weeks. Material composition within the bottom, bone-forming layer did not appear to affect the rate of scaffold degradation or tissue filling. However, no bone upgrowth into the chondral region was observed with any scaffold formulation. TGF-beta 1 loading in the top layer of scaffolds appeared to exert some therapeutic affect on tissue quality, but further studies are necessary for scaffold optimization. Yet, the excellent tissue filling and integration resulting from osteochondral implantation of these OPF-based scaffolds demonstrates their potential in cartilage repair strategies. (c) 2005 Wiley Periodicals, Inc.
引用
收藏
页码:156 / 167
页数:12
相关论文
共 43 条
[31]  
Sheehan DC., 1987, Theory and Practice of Histotechnology, VSecond
[32]   In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels [J].
Shin, H ;
Ruhé, PQ ;
Mikos, AG ;
Jansen, JA .
BIOMATERIALS, 2003, 24 (19) :3201-3211
[33]  
SILVER FH, 1995, OTOLARYNG CLIN N AM, V28, P847
[34]   Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle [J].
Solchaga, LA ;
Gao, JZ ;
Dennis, JE ;
Awadallah, A ;
Lundberg, M ;
Caplan, AI ;
Goldberg, VM .
TISSUE ENGINEERING, 2002, 8 (02) :333-347
[35]   Hyaluronan-based polymers in the treatment of osteochondral defects [J].
Solchaga, LA ;
Yoo, JU ;
Lundberg, M ;
Dennis, JE ;
Huibregtse, BA ;
Goldberg, VM ;
Caplan, AI .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2000, 18 (05) :773-780
[36]  
Stockwell RA., 1979, BIOL CARTILAGE CELLS
[37]   Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor [J].
Tabata, Y ;
Hijikata, S ;
Muniruzzaman, M ;
Ikada, Y .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 1999, 10 (01) :79-94
[38]   Thermally cross-linked oligo(poly(ethylene glycol) fumarate) hydrogels support osteogenic differentiation of encapsulated marrow stromal cells in vitro [J].
Temenoff, JS ;
Park, H ;
Jabbari, E ;
Conway, DE ;
Sheffield, TL ;
Ambrose, CG ;
Mikos, AG .
BIOMACROMOLECULES, 2004, 5 (01) :5-10
[39]   In vitro osteogenic differentiation of marrow stromal cells encapsulated in biodegradable hydrogels [J].
Temenoff, JS ;
Park, H ;
Jabbari, E ;
Sheffield, TL ;
LeBaron, RG ;
Ambrose, CG ;
Mikos, AG .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2004, 70A (02) :235-244
[40]  
VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279